Discover Great Companies Discover Great Clients
Companies Salaries Jobs
Jobs |
Jobs Companies Salary Majors

Company Overview

Development Stage

About the Company

[Summary] 肿瘤和其他重大疾病的抗体新药研发

南京维立志博生物科技股份有限公司是一家临床阶段的生物科技公司,致力于创新疗法的发现、开发及商业化,以满足中国及全球在肿瘤、自身免疫性疾病及其他重大疾病方面未获满足的医疗需求。
公司凭借专有技术平台及强大的药物开发能力,已设计合理且具差异化的包括12款创新候选药物在内的丰富管线,其中6款已成功进入临床阶段。公司的肿瘤产品组合提供广泛的癌症治疗选择,在单一治疗及联合治疗方面有巨大的潜力。
公司将不断拓展创新,为广大患者提供安全、有效、可及、可负担的新药,满足尚未满足的医药需求。

公司福利:
1. 缴纳五险一金
2. 周末双休、带薪年假、法定节假日
3. 年终奖金、节日福利
4. 交通补贴、午餐补贴、通讯补贴
5. 年度体检、定期组织团体建设活动
6. 绩效激励

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

维立志博 Financing History (1 rounds)

Manage
C+轮
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Amount: 1亿美元
  • Investor: 汉康资本,贞吉资本,深创投...

维立志博 How Fast Is Hiring Growing? (38 open positions)

Manage
Note: How fast is hiring at 南京维立志博生物科技股份有限公司 growing? 维立志博2025: 54 openings (up 69%), 2024: 32 openings (down 53%), 2023: 68 openings (up 39%), 2022: 49 openings (up 104%), 2021: 24 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

维立志博 Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Down 15%
  • 2024: Down 24%
  • 2023: Flat 0%-
  • 2022: Up 750%
维立志博 Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at 南京维立志博生物科技股份有限公司 growing? 维立志博Master's recruitment over the years: 2025: 11 openings (down 15%), 2024: 13 openings (down 24%), 2023: 17 openings (flat), 2022: 17 openings (up 750%), 2021: 2 openings.

维立志博 Doctoral Degree Job Demand Analysis

(More)
+100%
Growth Rate
2026 vs 2025
  • 2025: Flat 0%-
  • 2024: Down 71%
  • 2023: Up 17%
维立志博 Doctoral Hiring by Year: 2026 — 2 more jobs than 2025
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at 南京维立志博生物科技股份有限公司 growing? 维立志博Doctorate recruitment over the years: 2026: 4 openings (up 100%), 2025: 2 openings (flat), 2024: 2 openings (down 71%), 2023: 7 openings (up 17%), 2022: 6 openings.

维立志博 R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at 南京维立志博生物科技股份有限公司? Based on an analysis of 维立志博's job postings over the past year, "生物/制药/化工/环保类" demand: 41.7%, "医疗卫生/美容保健类": 30.1%, "科研类": 25.2%, "其他(研发和技术类)": 16.5%, "计算机/网络/技术类": 8.7%, "电子/电器/通信技术类": 4.9%. For reference only.

维立志博 — What Are the Salaries Like? (103 records)

Manage
维立志博 Salary Overview
salary range: 4.5K - 50K, 63.1% of roles pay ¥15-50K
Note: salary statistics are based on 103 salary records from the past year and depend on the job sample. For reference only.
How is the salary at 南京维立志博生物科技股份有限公司?维立志博63.1% of positions earn 15-50K, Undergraduate salary: ¥。Nanjing salary ranking top 15,生物/制药/化工/环保类 average salary ¥21.5K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of 维立志博

(More)
Are salaries high at 南京维立志博生物科技股份有限公司? We provide: 研究员,临床,分析,副总,检测,科学家,ir,bp,ra,生产技术,cto,fa,ma,qc,知识产权,项目管理,高级专员,cad,hr,pm. Click to view detailed salary analysis by job.

维立志博 honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

维立志博 Related Industry Tags

Tags are auto-annotated by keyword text matching and may be correlated. For reference only.

Job Category

  • 生物/制药/化工/环保类
    41.7% of total 41.7%
  • 经营管理类
    32% of total 32%
  • 医疗卫生/美容保健类
    30.1% of total 30.1%
  • 科研类
    25.2% of total 25.2%

Education

  • 本科
    49.5% of total 49.5%
  • 硕士
    43.7% of total 43.7%
  • 博士
    4.9% of total 4.9%
  • 大专
    1.9% of total 1.9%

Experience

  • 不限
    28.2% of total 28.2%
  • 5-10年
    27.2% of total 27.2%
  • 1-3年
    23.3% of total 23.3%
  • 3-5年
    21.4% of total 21.4%
View Detailed Analysis

What does 南京维立志博生物科技股份有限公司 require? Who is 维立志博 hiring? 维立志博 recruitment: 生物/制药/化工/环保类占比最多占41.7%,其次是经营管理类占32%. What education can get in at 维立志博? 本科占比最多占49.5%,其次是硕士占43.7%. High education required at 维立志博? 硕士占43.7%,博士占4.9%. Work experience required at 维立志博? 不限占比最多占28.2%,其次是5-10年占27.2%. Where are the job locations at 维立志博? 南京占比最多占73.8%,其次是上海占23.3%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 19,889.18万(元)
Legal Representative: XIAOQIANG KANG
Date Established:
Credit Code: 91320105057957145W
Registered Address: 南京市江北新区华康路122号加速器四期05栋

Partners & Suppliers

维立志博与信达生物共同开发PD-1/LAG-3双特异性抗体,信达生物获得中国大陆权益,维立志博保留海外权益。 Source
合作客户 战略合作/技术授权
维立志博将LBL-007(LAG-3抗体)的全球开发与商业化权益授权给百济神州,百济神州支付首付款、里程碑付款及销售分成。 Source
合作客户 战略合作/技术授权

People who follow 维立志博 also follow

维立志博 Competitors (Similar Companies)

“Clinical Development Services and Solutions Provider”
医药 抗体 CRO 临床研究
“派格生物医药拥有一条从高分子聚乙二醇合成到聚乙二醇药物修饰的上下游贯通的产业链。”
“Synchronize China's new drug technology and production processes with ”
单克隆抗体 抗体研发 生物医药 药物研发
“创新肿瘤及自身免疫性疾病抗体药物研发和生产”
“Helping patients access more effective medicines sooner”
生物制药 辅助生殖 生长激素 生物制品
新材料 阻燃剂 环保材料 橡胶
“Adhering to the corporate culture of science and excellence, committed”
胶粘剂 医药中间体 催化剂 树脂
医药 医药中间体 原料药 中间体
电气 电力设备 智能电网 开关设备
工业机器人 工业物联 工业物联网 智能机器人
“Power distribution, industrial control and automation”

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates